New painkiller copycat put to the test in healthy volunteers
NCT ID NCT07279155
First seen Jan 06, 2026 · Last updated Apr 30, 2026 · Updated 13 times
Summary
This study checked if a new version of a long-lasting painkiller (bupivacaine liposome injection) behaves the same in the body as the approved version. It involved 36 healthy adults who gave blood samples to measure drug levels. The goal was to confirm the new version is equivalent, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE LOCAL ANALGESIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Jilin University First Hospital
Changchun, Jilin, 130000, China
Conditions
Explore the condition pages connected to this study.